CVS HEALTH Corp
For the period ended Dec 31, 2023. Filed Feb 7, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 7, 2024
CVS$89.01+4.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Financial Statements and Supplementary Data
| Page | |
|---|---|
| Consolidated Statements of Operations for the years ended December 31, 2023, 2022 and 2021 | 109 |
| Consolidated Statements of Comprehensive Income for the years ended December 31, 2023, 2022 and 2021 | 110 |
| Consolidated Balance Sheets as of December 31, 2023 and 2022 | 111 |
| Consolidated Statements of Cash Flows for the years ended December 31, 2023, 2022 and 2021 | 112 |
| Consolidated Statements of Shareholders’ Equity for the years ended December 31, 2023, 2022 and 2021 | 114 |
| Notes to Consolidated Financial Statements | 115 |
| Reports of Independent Registered Public Accounting Firm (Public Company Accounting Oversight Board ID: 42) | 196 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.